,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,74268,6755,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,74268,6755,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,74268,6755,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,74268,6755,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,74268,6755,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,74268,6755,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,179,1,1,,74268,6755,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
7,248,1,1,,74268,6755,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
8,248,1,1,,87831,6755,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
9,256,1,1,,74268,6755,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
10,256,1,1,,87831,6755,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
11,608,1,6,,11537695,6755,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
12,875,1,2,,26749851,6755,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
13,880,2,1,,26749851,6755,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
14,880,2,1,,26749851,6755,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
15,880,2,1,,50107733,6755,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
16,880,2,1,,50107733,6755,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
17,881,2,2,,26749851,6755,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
18,884,1,2,,26749851,6755,Inconclusive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
19,885,1,2,,26749851,6755,Inactive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
20,887,1,2,,26749851,6755,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
21,889,1,3,,26749851,6755,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
22,892,1,2,,26749851,6755,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
23,893,1,2,,26749851,6755,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
24,893,1,2,,26749851,6755,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
25,894,2,1,,26749851,6755,Inconclusive,31542939.0,3248.0,28.1838,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
26,894,2,1,,50107733,6755,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
27,900,1,3,,26749851,6755,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
28,902,1,2,,26749851,6755,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
29,910,1,2,,26749851,6755,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
30,923,1,2,,26749851,6755,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
31,924,1,2,,26749851,6755,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
32,927,1,3,,26749851,6755,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
33,930,1,2,,26749851,6755,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
34,940,1,2,,26612356,6755,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
35,995,1,2,,26749851,6755,Inactive,66932916.0,5594.0,0.0316,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
36,1030,2,1,,26749851,6755,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
37,1030,2,1,,50107733,6755,Active,30582681.0,216.0,15.8489,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
38,1033,2,2,,11537695,6755,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
39,1379,1,2,,26749851,6755,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
40,1379,1,2,,50107733,6755,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
41,1422,1,1,,26612356,6755,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
42,1452,1,1,,26749851,6755,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
43,1454,1,1,,26749851,6755,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
44,1454,1,1,,50107733,6755,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
45,1457,1,1,,26749851,6755,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
46,1457,1,1,,50107733,6755,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
47,1458,1,1,,26749851,6755,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
48,1458,1,1,,50107733,6755,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
49,1460,1,3,,26749851,6755,Inconclusive,92096784.0,4137.0,8.9125,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
50,1460,1,3,,50107733,6755,Inconclusive,92096784.0,4137.0,17.7828,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
51,1463,1,1,,26749851,6755,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
52,1463,1,1,,50107733,6755,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
53,1467,1,3,,26749851,6755,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
54,1467,1,3,,50107733,6755,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
55,1468,1,1,,26749851,6755,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
56,1468,1,1,,50107733,6755,Inconclusive,92096784.0,4137.0,11.2202,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
57,1469,1,1,,26749851,6755,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
58,1469,1,1,,50107733,6755,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
59,1471,2,1,,50107733,6755,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
60,1476,2,1,,26749851,6755,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
61,1476,2,1,,50107733,6755,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
62,1477,1,1,,50107733,6755,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
63,1478,2,1,,26749851,6755,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
64,1478,2,1,,50107733,6755,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
65,1479,1,2,,26749851,6755,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
66,1479,1,2,,50107733,6755,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
67,1487,1,1,,26749851,6755,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
68,1490,2,1,,26749851,6755,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
69,1490,2,1,,50107733,6755,Active,10954339.0,,79.4328,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
70,1519,1,3,,26749851,6755,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
71,1549,1,2,,11537695,6755,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
72,1552,1,3,,11537695,6755,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
73,1637,1,2,,11537695,6755,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
74,1648,1,2,,11537695,6755,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
75,1766,1,1,,26749851,6755,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
76,1766,1,1,,26749851,6755,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
77,1766,1,1,,50107733,6755,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
78,1766,1,1,,50107733,6755,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
79,1768,1,1,,26749851,6755,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
80,1768,1,1,,26749851,6755,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
81,1768,1,1,,50107733,6755,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
82,1768,1,1,,50107733,6755,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
83,1865,1,1,,26749851,6755,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
84,1865,1,1,,50107733,6755,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
85,1948,1,1,,26749851,6755,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
86,2101,1,1,,26749851,6755,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
87,2101,1,1,,50107733,6755,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
88,2107,1,1,,26749851,6755,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
89,2107,1,1,,50107733,6755,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
90,2112,1,1,,26749851,6755,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
91,2112,1,1,,50107733,6755,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
92,2147,1,1,,26749851,6755,Inconclusive,221046486.0,,25.1189,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
93,2147,1,1,,50107733,6755,Inconclusive,221046486.0,,31.6228,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
94,2451,1,2,,26749851,6755,Inconclusive,122920737.0,,15.8114,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
95,2451,1,2,,50107733,6755,Inconclusive,122920737.0,,15.8114,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
96,2472,1,2,,26749851,6755,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
97,2472,1,2,,50107733,6755,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
98,2517,2,1,,26749851,6755,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
99,2517,2,1,,50107733,6755,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
100,2528,1,2,,26749851,6755,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
101,2528,1,2,,50107733,6755,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
102,2546,1,1,,26749851,6755,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
103,2546,1,1,,50107733,6755,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
104,2549,1,1,,26749851,6755,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
105,2549,1,1,,50107733,6755,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
106,2551,1,1,,26749851,6755,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
107,2551,1,1,,50107733,6755,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
108,21140,6,2,,103544392,6755,Unspecified,,,,,Solubility in water was determined,Other,6834390.0,
109,23482,3,3,,103544392,6755,Unspecified,,,,,Partition coefficient (logP),Other,6834390.0,
110,39233,6,1,,103544392,6755,Unspecified,,,,,Effective dose that would give a 25% increase in the survival time against the ascitic sarcoma 180 in mice,Other,6834390.0,
111,93531,9,5,,103544392,6755,Unspecified,82312013.0,,100.0,IC50,Inhibitory activity against HIV-1 integrase,Confirmatory,8691444.0,
112,93543,9,5,,103544392,6755,Unspecified,82312013.0,,100.0,IC50,Inhibitory activity against HIV-1 integrase,Confirmatory,8691444.0,
113,115276,3,5,,103544392,6755,Unspecified,,,,,"Tested for its ability to eliminate the infective trypomastigote form of Trypanosoma cruzi, Y strain present in blood of infected mice at the dose of 0.29 mM",Other,,
114,117228,6,2,,103544392,6755,Unspecified,,,,,Tested for acute toxicity which is the single dose given intraperitoneally that will kill one-half of the mice within 5 days,Other,6834390.0,
115,117488,3,3,,103544392,6755,Unspecified,,,,,Maximum survival by an optimum dose at 25 mg/kg in treated to that of untreated mice,Other,6834390.0,
116,152094,6,2,,103544392,6755,Unspecified,,,100.0,IC50,"In vitro antimalarial activity against human malaria parasite, P falciparum (Vietnam Smith strain)",Confirmatory,2033589.0,
117,155387,8,7,,103544392,6755,Inconclusive,129614.0,110813108.0,,,Inhibitory activity against papain using HPLC assay; Not tested,Other,11720861.0,
118,162196,9,5,,103544392,6755,Unspecified,75593047.0,,100.0,IC50,Inhibitory activity against HIV-1 protease,Confirmatory,8691444.0,
119,163631,9,2,,103544392,6755,Unspecified,,,150.0,IC50,Inhibitory activity against HRV 3Cpro using HPLC assay,Confirmatory,11720861.0,
120,308236,3,9,,103544392,6755,Unspecified,129614.0,110813108.0,,,Inhibition of papain at 1.3 mM after 20 mins,Other,17532221.0,
121,308238,3,3,,103544392,6755,Inactive,,,,,Inhibition of pig pancreatic elastase,Other,17532221.0,
122,309363,3,3,,103544392,6755,Unspecified,,,,,Antiinflammatory activity in CD1 mouse assessed as inhibition of croton oil-induced ear oedema at 0.3 umol/cm^2 after 6 hrs,Other,17768049.0,
123,326467,9,5,,103544392,6755,Unspecified,123948.0,3620.0,675.0,IC50,Inhibition of purified human recombinant IDO,Confirmatory,18318466.0,
124,349291,3,3,,103544392,6755,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 250 ug/ml after 4 hrs by XTT assay relative to control,Other,18093697.0,
125,349292,3,3,,103544392,6755,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 125 ug/ml after 4 hrs by XTT assay relative to control,Other,18093697.0,
126,349293,3,3,,103544392,6755,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 62.5 ug/ml after 4 hrs by XTT assay relative to control,Other,18093697.0,
127,349294,3,3,,103544392,6755,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 31.2 ug/ml after 4 hrs by XTT assay relative to control,Other,18093697.0,
128,349295,3,3,,103544392,6755,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 15.6 ug/ml after 4 hrs by XTT assay relative to control,Other,18093697.0,
129,349296,3,3,,103544392,6755,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 7.8 ug/ml after 4 hrs by XTT assay relative to control,Other,18093697.0,
130,349297,3,3,,103544392,6755,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 3.9 ug/ml after 4 hrs by XTT assay relative to control,Other,18093697.0,
131,349300,7,1,,103544392,6755,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as inhibition of biofilm formation at 31.3 ug/ml after 48 hrs,Other,18093697.0,
132,349301,3,3,,103544392,6755,Inactive,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as effect on bacterial growth after 4 hrs by XTT assay relative to control,Other,18093697.0,
133,485281,1,1,,26749851,6755,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
134,485290,1,1,,26749851,6755,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
135,485290,1,1,,50107733,6755,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
136,504327,1,1,,26749851,6755,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
137,504847,1,1,,26749851,6755,Active,63054845.0,7421.0,17.7828,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
138,504847,1,1,,50107733,6755,Active,63054845.0,7421.0,8.9125,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
139,504865,1,1,,26749851,6755,Active,118600387.0,7398.0,50.1187,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
140,566699,3,7,,103544392,6755,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1 mM after 10 mins,Other,21189019.0,
141,566700,3,7,,103544392,6755,Unspecified,126407.0,240.0,,,Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay,Other,21189019.0,
142,566701,3,8,,103544392,6755,Unspecified,50402185.0,,,,Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay,Other,21189019.0,
143,566702,2,9,,103544392,6755,Unspecified,116852.0,4312.0,,,Inhibition of human recombinant MMP1 at 1 mM after 30 mins,Other,21189019.0,
144,566703,3,7,,103544392,6755,Unspecified,116856.0,4313.0,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,Other,21189019.0,
145,566704,2,9,,103544392,6755,Unspecified,116857.0,4314.0,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,Other,21189019.0,
146,566705,3,7,,103544392,6755,Unspecified,116862.0,4317.0,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,Other,21189019.0,
147,566706,3,7,,103544392,6755,Unspecified,269849668.0,4318.0,,,Inhibition of human recombinant MMP9 at 1 mM after 30 mins,Other,21189019.0,
148,588579,1,1,,26749851,6755,Inconclusive,7705344.0,51426.0,35.4813,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
149,602332,1,1,,26749851,6755,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
150,624263,1,1,,26749851,6755,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
151,624263,1,1,,26749851,6755,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
152,660266,2,2,,103544392,6755,Unspecified,,,2500.0,IC50,Trypanocidal activity against bloodstream form of Trypanosoma cruzi Y isolated from albino mouse blood after 24 hrs by neubauer chamber analysis,Confirmatory,22483633.0,
153,686978,1,1,,26749851,6755,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
154,686978,1,1,,50107733,6755,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
155,686979,1,1,,26749851,6755,Inconclusive,79154014.0,55775.0,23.1093,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
156,686979,1,1,,50107733,6755,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
157,720532,1,1,,26749851,6755,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
158,720532,1,1,,50107733,6755,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
159,720533,1,1,,26749851,6755,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
160,720533,1,1,,50107733,6755,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
161,720579,2,1,,26749851,6755,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
162,720580,1,1,,26749851,6755,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
163,723185,1,2,,103544392,6755,Unspecified,,,2500.0,IC50,Antitrypanosomal activity against Trypanosoma cruzi Y bloodstream trypomastigotes isolated from infected Swiss mouse blood assessed as lysis level after 24 hrs,Confirmatory,23279867.0,
164,736842,2,2,,103544392,6755,Unspecified,,,100.0,TC50,Neurotoxicity in mouse HT22 cells assessed as cell viability after 24 hrs by MTS assay,Confirmatory,23327468.0,
165,736843,1,3,,103544392,6755,Unspecified,,,,,"Therapeutic index, ratio of cytotoxic TC50 for mouse HT22 cells to neuroprotective PD50 for mouse HT22 cells",Other,23327468.0,
166,736844,2,2,,103544392,6755,Active,,,1.005,PD50,Neuroprotective activity in mouse HT22 cells assessed as prevention from glutamate-induced oxidative cell death by MTS assay,Confirmatory,23327468.0,
167,977599,1,1,,103544392,6755,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
168,977602,1,2,,103544392,6755,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
169,1059252,1,1,,103544392,6755,Active,,,,,Inhibition of Wolinella succinogenes succinate/quinone reductase at 20 uM,Other,24251984.0,
170,1059253,1,1,,103544392,6755,Active,,,,,Inhibition of Wolinella succinogenes quinol/fumarate reductase at 20 uM,Other,24251984.0,
171,1064150,1,2,,103544392,6755,Unspecified,,,100.0,IC50,Growth inhibition of human LoVo cells by MTT assay,Confirmatory,24374273.0,
172,1064151,1,1,,103544392,6755,Unspecified,,,100.0,IC50,Growth inhibition of human PC3 cells by MTT assay,Confirmatory,24374273.0,
173,1064152,1,2,,103544392,6755,Unspecified,,,100.0,IC50,Growth inhibition of human SK-MEL-28 cells by MTT assay,Confirmatory,24374273.0,
174,1064153,1,1,,103544392,6755,Active,,,31.0,IC50,Growth inhibition of human Hs683 cells by MTT assay,Confirmatory,24374273.0,
175,1064154,1,1,,103544392,6755,Unspecified,,,100.0,IC50,Growth inhibition of human U373 cells by MTT assay,Confirmatory,24374273.0,
176,1064155,1,2,,103544392,6755,Unspecified,,,58.0,IC50,Growth inhibition of human A549 cells by MTT assay,Confirmatory,24374273.0,
177,1083211,3,1,,103544392,6755,Unspecified,,,,,Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition in King's B full medium measured at pH 7.2 after overnight incubation by suspension culture assay,Other,23163769.0,
178,1159524,1,1,,26749851,6755,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
179,1159524,1,1,,50107733,6755,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
180,1159550,3,1,,252402608,6755,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
181,1159580,2,1,,268735833,6755,Active,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
182,1159607,2,1,,312996502,6755,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
183,1179567,1,1,,103544392,6755,Unspecified,,,100.0,IC50,Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay,Confirmatory,24913712.0,
184,1179568,1,1,,103544392,6755,Unspecified,,,100.0,IC50,Cytotoxicity against human SAS cells assessed as reduction in cell viability after 48 hrs by MTT assay,Confirmatory,24913712.0,
185,1179569,1,1,,103544392,6755,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus at 100 ug/well after 24 hrs by well diffusion assay,Other,24913712.0,
186,1179570,1,1,,103544392,6755,Inactive,,,,,Antibacterial activity against Pseudomonas aeruginosa MTCC 201 at 100 ug/well after 24 hrs by well diffusion assay,Other,24913712.0,
187,1179571,1,1,,103544392,6755,Unspecified,,,,,Antifungal activity against fluconazole-resistant Candida albicans at 100 ug/well after 24 hrs by well diffusion assay,Other,24913712.0,
188,1179572,1,1,,103544392,6755,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus by NCCLS method,Other,24913712.0,
189,1179573,1,1,,103544392,6755,Unspecified,,,,,Antifungal activity against fluconazole-resistant Candida albicans by NCCLS method,Other,24913712.0,
190,1182273,1,2,,103544392,6755,Unspecified,20139861.0,26191.0,,,Inhibition of LYP (unknown origin) incubated for 30 mins at 25 degC before addition of DiFMUP substrate in presence of 5 uM zinc acetate,Other,24997687.0,
191,1182274,1,2,,103544392,6755,Active,20139861.0,26191.0,5.6,IC50,Inhibition of LYP (unknown origin) using DiFMUP substrate incubated for 2 hrs,Confirmatory,24997687.0,
192,1259310,1,1,,333495225,6755,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
193,1259389,1,1,,124636726,6755,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
194,1259407,1,1,,363904198,6755,Inactive,,,,,CCRIS mutagenicity studies,Other,,
195,1259423,1,2,,354749113,6755,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
196,1259423,1,2,,354755733,6755,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
197,1259423,1,2,,354913586,6755,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
